Atlas Trials

Neoplasms, Nerve Tissue

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neoplasms, Nerve Tissue

RecordFirmDate
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC (NCT05153408)Blueprint Medicines Corporation2022-01-13
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC (NCT04862780)Blueprint Medicines Corporation2021-06-29
Spanish Series of Patients Treated With the Radionuclide Lutetium177 (NCT04949282)Sociedad Española de Medicina Nuclear e Imagen Molecular2021-05-10
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. (NCT04388033)Second Affiliated Hospital, Zhejiang University, School of Medicine2020-12-01
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC (NCT04697446)Blueprint Medicines Corporation2020-12-01
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT04222972)Hoffmann-La Roche2020-07-24
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients (NCT04446416)NaviFUS Corporation2020-07-21
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors (NCT03911388)M.D. Anderson Cancer Center2019-09-12
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients (NCT03626896)NaviFUS Corporation2018-08-17
Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST) (NCT03109301)National Cancer Institute (NCI)2017-04-07
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385)Hoffmann-La Roche2017-03-17
A Combined Cell Therapy Approach to the Treatment of Neuroblastoma (NCT02745756)H. Lee Moffitt Cancer Center and Research Institute2016-04-14
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients (NCT01579253)Ludwig-Maximilians - University of Munich2012-04-01
Vorasidenib Expanded Access Program (NCT05592743)Servier

Track Neoplasms, Nerve Tissue automatically

Every clearance here is in the API, with alerts when new ones post.